The effect of some neurotropic drugs on neuroleptic hypersensitivity of dopamine receptors in the central nervous system.
D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000818:Animals; D001058:Apomorphine / Q000627:therapeutic use*; D003342:Corpus Striatum / Q000473:pathology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006220:Haloperidol / Q000009:adverse effects*; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use*; D010889:Piracetam / Q000627:therapeutic use; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D014282:Trihexyphenidyl / Q000627:therapeutic use
D010276:Parasympatholytics; D011954:Receptors, Dopamine; D014282:Trihexyphenidyl; D000255:Adenosine Triphosphate; D003520:Cyclophosphamide; D006220:Haloperidol; D001058:Apomorphine; D007099:Imipramine; D010889:Piracetam